| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | TESARO INC | 10,275,113 | 1,381,797,000 | 54.94% | ||
| 2 | ARDELYX INC COM | 14,083,582 | 199,987,000 | 7.95% | ||
| 3 | DERMIRA INC | 3,506,649 | 106,357,000 | 4.23% | ||
| 4 | EPIZYME INC COM | 6,260,851 | 75,756,000 | 3.01% | ||
| 5 | SENSEONICS HOLDINGS INC | 26,305,286 | 70,235,000 | 2.79% | ||
| 6 | ACHAOGEN INC COM | 5,215,125 | 67,901,000 | 2.70% | ||
| 7 | GROUPON INC | 20,075,762 | 66,652,000 | 2.65% | ||
| 8 | Crispr Therapeutics | 3,220,728 | 65,252,000 | 2.59% | ||
| 9 | RA PHARMACEUTICALS INC | 3,493,636 | 53,068,000 | 2.11% | ||
| 10 | GLYCOMIMETICS INC | 8,584,128 | 52,363,000 | 2.08% | ||
| 11 | CLOVIS ONCOLOGY INC | 1,139,890 | 50,634,000 | 2.01% | ||
| 12 | PROTEOSTASIS THERAPEUTICS IN | 3,556,778 | 43,606,000 | 1.73% | ||
| 13 | ADAPTIMMUNE THERAPEUTICS PLC | 9,880,999 | 40,018,000 | 1.59% | ||
| 14 | LEXICON PHARMACEUTICALS | 2,382,286 | 32,947,000 | 1.31% | ||
| 15 | CARE COM INC COM | 3,260,989 | 27,947,000 | 1.11% | ||
| 16 | AEROHIVE NETWORKS INC | 4,673,536 | 26,639,000 | 1.06% | ||
| 17 | NEVRO CORP | 359,678 | 26,134,000 | 1.04% | ||
| 18 | TREVENA INC | 3,811,691 | 22,413,000 | 0.89% | ||
| 19 | ENDOLOGIX INC | 2,490,204 | 14,244,000 | 0.57% | ||
| 20 | Tracon Pharmaceuticals Inc | 2,759,217 | 13,520,000 | 0.54% | ||
| 21 | Strongbridge Biopharma plc | 4,141,308 | 9,939,000 | 0.40% | ||
| 22 | AURINIA PHARMACEUTICALS INC | 4,067,743 | 8,542,000 | 0.34% | ||
| 23 | CASCADIAN THERAPEUTICS | 1,791,666 | 7,722,000 | 0.31% | ||
| 24 | RIGEL PHARMACEUTICAL INC | 3,243,150 | 7,719,000 | 0.31% | ||
| 25 | AVEO PHARMACEUTICALS INC | 10,362,694 | 5,596,000 | 0.22% | ||
| 26 | MIRNA THERAPEUTICS INC | 2,974,811 | 5,355,000 | 0.21% | ||
| 27 | DASAN ZHONE SOLUTIONS INC | 4,781,290 | 4,704,000 | 0.19% | ||
| 28 | Sunesis Pharmaceuticals, Inc. | 1,298,274 | 4,700,000 | 0.19% | ||
| 29 | ARCA BIOPHARMA INCORPORATED COM PAR .001 | 1,460,209 | 4,162,000 | 0.17% | ||
| 30 | CHAMPIONS ONCOLOGY INC | 1,562,500 | 3,953,000 | 0.16% | ||
| 31 | Roka Bioscience Inc | 893,471 | 3,788,000 | 0.15% | ||
| 32 | AKARI THERAPEUTICS PLC | 452,167 | 3,183,000 | 0.13% | ||
| 33 | ArQule Inc | 2,520,316 | 3,176,000 | 0.13% | ||
| 34 | Zosano Pharma Corp | 2,052,809 | 1,601,000 | 0.06% | ||
| 35 | PARATEK PHARMACEUTICALS INC | 66,245 | 1,020,000 | 0.04% | ||
| 36 | Agile Therapeutics, Inc. | 133,488 | 761,000 | 0.03% | ||
| 37 | OREXIGEN THERAPEUTICS INC | 370,900 | 645,000 | 0.03% | ||
| 38 | Cerecor Inc | 595,435 | 524,000 | 0.02% | ||
| 39 | Catalyst Biosciences | 652,380 | 424,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001012975-17-000099, filed 2017.02.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
